Quotient Ltd
Eysins, V8 · Founded 2012 · CIK 0001596946 · Biotech · Defunct
Somatic genomics platform for therapeutic development
quotient-tx.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $92M
- 3 Form D · Nov 2017
- 107 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20142015201620172018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $27,066,500 | |
| Private capital raised | Form D · SEC | $24,999,998 | |
| Private capital raised | Form D · SEC | $40,159,214 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1937 | DeepSpace Storage Systems Inc. | — | $1.3M |
| 1938 | Centrexion Therapeutics Corp | — | $189M |
| 1939 | Aktis Oncology | — | $175M |
| 1940 | Quotient Ltd | — | $92M |
| 1941 | Myota, Inc. | — | $16M |
| 1942 | AXIOMX INC | — | — |
| 1943 | Sparrow Pharmaceuticals | — | $73M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Thomas BolognaDirector
- Roland BoydExecutive Officer
- Paul CowanDirector · Executive Officer
- Edward FarrellExecutive Officer
- Frederick HallsworthDirector
- Christopher LindopExecutive Officer
- Brian McDonoughDirector
- Sarah O'ConnorDirector
- Zubeen ShroffDirector
- Jeremy StackawitzExecutive Officer
- Stephen UngerExecutive Officer
- Heino von ProndzynskiDirector
- John WilkersonDirector
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.